CWM
ABBV icon

Chronos Wealth Management’s AbbVie ABBV Stock Holding History

Chronos Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Hold
1,236
– – 0.14% 37
2026
Q1 		$269K Sell
1,236
-8
-0.6% -$1.77K 0.13% 38
2025
Q4 		$284K Hold
1,244
– – 0.13% 37
2025
Q3 		$288K Hold
1,244
– – 0.14% 36
2025
Q2 		$231K Hold
1,244
– – 0.12% 38
2025
Q1 		$261K Hold
1,244
– – 0.14% 33
2024
Q4 		$221K Hold
1,244
– – 0.11% 42
2024
Q3 		$246K Buy
+1,244
New +$232K 0.13% 38

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Chronos Wealth Management's ABBV Position: Q2 2026 in Review

Chronos Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,236 shares worth $311K. The position accounts for 0.14% of the portfolio, ranked #37.

Chronos Wealth Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 1,993 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chronos Wealth Management held 1,236 shares of AbbVie worth $311K as of Q2 2026.
  • Chronos Wealth Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.14% of Chronos Wealth Management's portfolio in Q2 2026, its #37 holding.
  • Chronos Wealth Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 1,993 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chronos Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.